News | March 01, 2009

ASTRO Applauds Obama Plan to Close Self-Referral Loopholes

March 2, 2009 - The American Society for Radiation Oncology (ASTRO) applauds President Obama’s healthcare reform plan to double funding for cancer research and close loopholes that are weakening the Medicare program.

ASTRO believes that the integrity of the Medicare program and quality patient care is being compromised by loopholes in the physician self-referral law - or Stark Law. One particular loophole, called the in-office ancillary exception (IOAE), has become the "loophole that has swallowed the rule".

"There is evidence that some physicians are using the ancillary exception to drop 'turn-key' radiation therapy services into group practices to maximize profit. We are afraid these arrangements compromise the quality of care, limit access, constrain patient choice from the full range of treatment options and result in overutilization of certain treatments," said Laura I. Thevenot, ASTRO's CEO. "ASTRO is committed to working with President Obama and Congress to prevent profit-motivated self-referrals and preserve the independent judgment and choice that patients deserve in making life and death decisions."

ASTRO is asking President Obama and Congress to close the IOAE loophole and responsibly address abuses of the self-referral law. By taking these actions, it believes budgetary savings may result that help advance the President's healthcare priorities. For instance, savings could help increase funding for cancer research or expand coverage, both of which are critical to keep people healthy, save lives and stimulate the economy.

ASTRO strongly supports comprehensive healthcare reform and looks forward to working with the President and Congress to expand coverage of the uninsured, double funding for life-saving cancer research, and strengthen Medicare by fixing its physician payment system and protecting the program's integrity.

ASTRO is the largest radiation oncology society in the world, with more than 10,000 members who specialize in treating patients with radiation therapies. As the leading organization in radiation oncology, biology and physics, the Society is dedicated to improving patient care through education, clinical practice, advancement of science and advocacy.

For more information: www.astro.org

Related Content

Proton Therapy Lowers Risk of Side Effects Compared to Conventional Radiation
News | Proton Therapy | May 23, 2019
Cancer patients getting proton therapy instead of traditional photon radiation are at a significantly lower risk of...
Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res
Varian Acquiring Cancer Treatment Services International
News | Radiation Therapy | May 21, 2019
Varian Medical Systems announced it has entered into a definitive agreement to acquire India’s Cancer Treatment...
Videos | Radiation Therapy | May 21, 2019
This is a walk through of the ViewRay MRIdian MRI-guided radiotherapy system installed at ...
Partial Breast Irradiation Effective, Convenient Treatment Option for Low-Risk Breast Cancer
News | Radiation Therapy | May 20, 2019
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast...
New Method Improves Ability to Measure and Maximize Radiation Therapy Dose
News | Radiation Therapy | May 14, 2019
Delivering just the right dose of radiation for cancer patients is a delicate balance in their treatment regime....
Sponsored Content | Videos | Radiation Oncology | May 13, 2019
At ASTRO 2018, Accuray showcased new patient-fi
Radiotherapy After Chemo May Improve Survival in Advanced Hodgkin's Lymphoma Patients
News | Radiation Therapy | May 10, 2019
Patients with advanced Hodgkin's lymphoma who have large tumors at the time of diagnosis may benefit from radiotherapy...
IBA Partnering to Develop Advanced Digital Proton Therapy Technologies in Belgium
News | Proton Therapy | May 10, 2019
IBA (Ion Beam Applications SA) announced a research agreement with Skandionkliniken, Université Catholique de Louvain...